Valproate sodium and Neuropsychiatric lupus - a phase IV clinical study of FDA data


No or few reports are found.

The phase IV clinical study is created by eHealthMe based on reports from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Oct, 03, 2023

No or few reports are found.

What is Valproate Sodium?

Valproate sodium has active ingredients of valproate sodium. It is used in epilepsy. Currently, eHealthMe is studying from 22,435 Valproate sodium users.

What is Neuropsychiatric Lupus?

Neuropsychiatric lupus (the various psychiatric and neurologic symptoms due to a multi system inflammatory disorder) is found to be associated with 111 drugs and 34 conditions by eHealthMe. Currently, we are studying 202 people who have Neuropsychiatric lupus.

Do you take Valproate sodium and have Neuropsychiatric lupus?

Check whether Neuropsychiatric lupus is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Valproate sodium side effects by duration, gender and age:

Neuropsychiatric lupus treatments and more:

All the drugs that are associated with Neuropsychiatric lupus:

All the conditions that are associated with Neuropsychiatric lupus:

How the study uses the data?

The study uses data from the FDA. It is based on valproate sodium (the active ingredients of Valproate sodium) and Valproate sodium (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: